Literature DB >> 27725853

Bone morphogenetic protein 9 (BMP9) induces effective bone formation from reversibly immortalized multipotent adipose-derived (iMAD) mesenchymal stem cells.

Shun Lu1, Jing Wang2, Jixing Ye3, Yulong Zou2, Yunxiao Zhu4, Qiang Wei2, Xin Wang5, Shengli Tang6, Hao Liu2, Jiaming Fan2, Fugui Zhang2, Evan M Farina7, Maryam M Mohammed7, Dongzhe Song5, Junyi Liao2, Jiayi Huang2, Dan Guo2, Minpeng Lu2, Feng Liu2, Jianxiang Liu8, Li Li3, Chao Ma6, Xue Hu2, Michael J Lee7, Russell R Reid9, Guillermo A Ameer10, Dongsheng Zhou11, Tongchuan He2.   

Abstract

Regenerative medicine and bone tissue engineering using mesenchymal stem cells (MSCs) hold great promise as an effective approach to bone and skeletal reconstruction. While adipose tissue harbors MSC-like progenitors, or multipotent adipose-derived cells (MADs), it is important to identify and characterize potential biological factors that can effectively induce osteogenic differentiation of MADs. To overcome the time-consuming and technically challenging process of isolating and culturing primary MADs, here we establish and characterize the reversibly immortalized mouse multipotent adipose-derived cells (iMADs). The isolated mouse primary inguinal MAD cells are reversibly immortalized via the retrovirus-mediated expression of SV40 T antigen flanked with FRT sites. The iMADs are shown to express most common MSC markers. FLP-mediated removal of SV40 T antigen effectively reduces the proliferative activity and cell survival of iMADs, indicating the immortalization is reversible. Using the highly osteogenic BMP9, we find that the iMADs are highly responsive to BMP9 stimulation, express multiple lineage regulators, and undergo osteogenic differentiation in vitro upon BMP9 stimulation. Furthermore, we demonstrate that BMP9-stimulated iMADs form robust ectopic bone with a thermoresponsive biodegradable scaffold material. Collectively, our results demonstrate that the reversibly immortalized iMADs exhibit the characteristics of multipotent MSCs and are highly responsive to BMP9-induced osteogenic differentiation. Thus, the iMADs should provide a valuable resource for the study of MAD biology, which would ultimately enable us to develop novel and efficacious strategies for MAD-based bone tissue engineering.

Entities:  

Keywords:  BMP9; adipose-derived stem cells; bone formation; immortalized progenitor cells; mesenchymal stem cells; tissue engineering

Year:  2016        PMID: 27725853      PMCID: PMC5040671     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  126 in total

Review 1.  Cell-mediated and direct gene therapy for bone regeneration.

Authors:  Akikazu Ishihara; Alicia L Bertone
Journal:  Expert Opin Biol Ther       Date:  2012-02-13       Impact factor: 4.388

Review 2.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

3.  Nonintegrating knockdown and customized scaffold design enhances human adipose-derived stem cells in skeletal repair.

Authors:  Benjamin Levi; Jeong S Hyun; Emily R Nelson; Shuli Li; Daniel T Montoro; Derrick C Wan; Fang Jun Jia; Jason C Glotzbach; Aaron W James; Min Lee; Mei Huang; Natalina Quarto; Geoffrey C Gurtner; Joseph C Wu; Michael T Longaker
Journal:  Stem Cells       Date:  2011-12       Impact factor: 6.277

4.  In vivo bone formation following transplantation of human adipose-derived stromal cells that are not differentiated osteogenically.

Authors:  Oju Jeon; Jong Won Rhie; Il-Kuen Kwon; Jae-Hwan Kim; Byung-Soo Kim; Soo-Hong Lee
Journal:  Tissue Eng Part A       Date:  2008-08       Impact factor: 3.845

5.  Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.

Authors:  Rui Li; Zhongliang Hu; Shi-Yong Sun; Zhuo G Chen; Taofeek K Owonikoko; Gabriel L Sica; Suresh S Ramalingam; Walter J Curran; Fadlo R Khuri; Xingming Deng
Journal:  Mol Cancer Ther       Date:  2013-07-26       Impact factor: 6.261

6.  Development of a bone reconstruction technique using a solid free-form fabrication (SFF)-based drug releasing scaffold and adipose-derived stem cells.

Authors:  Jin Woo Lee; Ki-Joo Kim; Kyung Shin Kang; Shaochen Chen; Jong-Won Rhie; Dong-Woo Cho
Journal:  J Biomed Mater Res A       Date:  2012-11-27       Impact factor: 4.396

7.  Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.

Authors:  Liang Chen; Wei Jiang; Jiayi Huang; Bai-Cheng He; Guo-Wei Zuo; Wenli Zhang; Qing Luo; Qiong Shi; Bing-Qiang Zhang; Eric R Wagner; Jinyong Luo; Min Tang; Christian Wietholt; Xiaoji Luo; Yang Bi; Yuxi Su; Bo Liu; Stephanie H Kim; Connie J He; Yawen Hu; Jikun Shen; Farbod Rastegar; Enyi Huang; Yanhong Gao; Jian-Li Gao; Jian-Zhong Zhou; Russell R Reid; Hue H Luu; Rex C Haydon; Tong-Chuan He; Zhong-Liang Deng
Journal:  J Bone Miner Res       Date:  2010-11       Impact factor: 6.741

8.  Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance.

Authors:  Sahitya K Denduluri; Olumuyiwa Idowu; Zhongliang Wang; Zhan Liao; Zhengjian Yan; Maryam K Mohammed; Jixing Ye; Qiang Wei; Jing Wang; Lianggong Zhao; Hue H Luu
Journal:  Genes Dis       Date:  2015-03-01

9.  TqPCR: A Touchdown qPCR Assay with Significantly Improved Detection Sensitivity and Amplification Efficiency of SYBR Green qPCR.

Authors:  Qian Zhang; Jing Wang; Fang Deng; Zhengjian Yan; Yinglin Xia; Zhongliang Wang; Jixing Ye; Youlin Deng; Zhonglin Zhang; Min Qiao; Ruifang Li; Sahitya K Denduluri; Qiang Wei; Lianggong Zhao; Shun Lu; Xin Wang; Shengli Tang; Hao Liu; Hue H Luu; Rex C Haydon; Tong-Chuan He; Li Jiang
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

10.  BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling.

Authors:  Ni Tang; Wen-Xin Song; Jinyong Luo; Xiaoji Luo; Jin Chen; Katie A Sharff; Yang Bi; Bai-Cheng He; Jia-Yi Huang; Gao-Hui Zhu; Yu-Xi Su; Wei Jiang; Min Tang; Yun He; Yi Wang; Liang Chen; Guo-Wei Zuo; Jikun Shen; Xiaochuan Pan; Russell R Reid; Hue H Luu; Rex C Haydon; Tong-Chuan He
Journal:  J Cell Mol Med       Date:  2008-11-03       Impact factor: 5.295

View more
  28 in total

1.  Bone Morphogenetic Protein-9-Stimulated Adipocyte-Derived Mesenchymal Progenitors Entrapped in a Thermoresponsive Nanocomposite Scaffold Facilitate Cranial Defect Repair.

Authors:  Cody S Lee; Elliot S Bishop; Zari Dumanian; Chen Zhao; Dongzhe Song; Fugui Zhang; Yunxiao Zhu; Guillermo A Ameer; Tong-Chuan He; Russell R Reid
Journal:  J Craniofac Surg       Date:  2019-09       Impact factor: 1.046

2.  Reversibly immortalized human umbilical cord-derived mesenchymal stem cells (UC-MSCs) are responsive to BMP9-induced osteogenic and adipogenic differentiation.

Authors:  Yi Shu; Chao Yang; Xiaojuan Ji; Linghuan Zhang; Yang Bi; Ke Yang; Mengjia Gong; Xing Liu; Qi Guo; Yuxi Su; Xiangyang Qu; Guoxin Nan; Chen Zhao; Zongyue Zeng; Xinyi Yu; Ruyi Zhang; Shujuan Yan; Jiayan Lei; Ke Wu; Ying Wu; Liping An; Shifeng Huang; Cheng Gong; Chengfu Yuan; Wei Liu; Bo Huang; Yixiao Feng; Bo Zhang; Zhengyu Dai; Yi Shen; Wenping Luo; Xi Wang; Rex C Haydon; Hue H Luu; Russell R Reid; Jennifer Moriatis Wolf; Michael J Lee; Tong-Chuan He; Yasha Li
Journal:  J Cell Biochem       Date:  2018-08-04       Impact factor: 4.429

3.  Leptin Potentiates BMP9-Induced Osteogenic Differentiation of Mesenchymal Stem Cells Through the Activation of JAK/STAT Signaling.

Authors:  Bo Zhang; Lijuan Yang; Zongyue Zeng; Yixiao Feng; Xi Wang; Xiaoxing Wu; Huaxiu Luo; Jing Zhang; Meng Zhang; Mikhail Pakvasa; William Wagstaff; Fang He; Yukun Mao; Kevin Qin; Huimin Ding; Yongtao Zhang; Changchun Niu; Meng Wu; Xia Zhao; Hao Wang; Linjuan Huang; Dayao Shi; Qing Liu; Na Ni; Kai Fu; Aravind Athiviraham; Jennifer Moriatis Wolf; Michael J Lee; Kelly Hynes; Jason Strelzow; Mostafa El Dafrawy; Yayi Xia; Tong-Chuan He
Journal:  Stem Cells Dev       Date:  2020-03-09       Impact factor: 3.272

4.  Noncanonical Wnt signaling plays an important role in modulating canonical Wnt-regulated stemness, proliferation and terminal differentiation of hepatic progenitors.

Authors:  Jiaming Fan; Qiang Wei; Junyi Liao; Yulong Zou; Dongzhe Song; Dongmei Xiong; Chao Ma; Xue Hu; Xiangyang Qu; Liqun Chen; Li Li; Yichun Yu; Xinyi Yu; Zhicai Zhang; Chen Zhao; Zongyue Zeng; Ruyi Zhang; Shujuan Yan; Tingting Wu; Xingye Wu; Yi Shu; Jiayan Lei; Yasha Li; Wenwen Zhang; Rex C Haydon; Hue H Luu; Ailong Huang; Tong-Chuan He; Hua Tang
Journal:  Oncotarget       Date:  2017-04-18

Review 5.  Recent Advances and Future of Gene Therapy for Bone Regeneration.

Authors:  Galina Shapiro; Raphael Lieber; Dan Gazit; Gadi Pelled
Journal:  Curr Osteoporos Rep       Date:  2018-08       Impact factor: 5.096

6.  A functional autophagy pathway is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs).

Authors:  Xia Zhao; Bo Huang; Hao Wang; Na Ni; Fang He; Qing Liu; Deyao Shi; Connie Chen; Piao Zhao; Xi Wang; William Wagstaff; Mikhail Pakvasa; Andrew Blake Tucker; Michael J Lee; Jennifer Moriatis Wolf; Russell R Reid; Kelly Hynes; Jason Strelzow; Sherwin H Ho; Tengbo Yu; Jian Yang; Le Shen; Tong-Chuan He; Yongtao Zhang
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  Evaluation of the optimal dosage of BMP-9 through the comparison of bone regeneration induced by BMP-9 versus BMP-2 using an injectable microparticle embedded thermosensitive polymeric carrier in a rat cranial defect model.

Authors:  Bipin Gaihre; Angshuman Bharadwaz; Janitha M Unagolla; Ambalangodage C Jayasuriya
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2021-06-10

8.  Mesenchymal stem cells overexpressing BMP-9 by CRISPR-Cas9 present high in vitro osteogenic potential and enhance in vivo bone formation.

Authors:  Gileade P Freitas; Helena B Lopes; Alann T P Souza; Maria Paula O Gomes; Georgia K Quiles; Jonathan Gordon; Coralee Tye; Janet L Stein; Gary S Stein; Jane B Lian; Marcio M Beloti; Adalberto L Rosa
Journal:  Gene Ther       Date:  2021-03-08       Impact factor: 4.184

9.  CRISPR/Cas9-mediated reversibly immortalized mouse bone marrow stromal stem cells (BMSCs) retain multipotent features of mesenchymal stem cells (MSCs).

Authors:  Xue Hu; Li Li; Xinyi Yu; Ruyi Zhang; Shujuan Yan; Zongyue Zeng; Yi Shu; Chen Zhao; Xingye Wu; Jiayan Lei; Yasha Li; Wenwen Zhang; Chao Yang; Ke Wu; Ying Wu; Liping An; Shifeng Huang; Xiaojuan Ji; Cheng Gong; Chengfu Yuan; Linghuan Zhang; Wei Liu; Bo Huang; Yixiao Feng; Bo Zhang; Rex C Haydon; Hue H Luu; Russell R Reid; Michael J Lee; Jennifer Moriatis Wolf; Zebo Yu; Tong-Chuan He
Journal:  Oncotarget       Date:  2017-12-05

10.  lncRNA H19 mediates BMP9-induced osteogenic differentiation of mesenchymal stem cells (MSCs) through Notch signaling.

Authors:  Junyi Liao; Xinyi Yu; Xue Hu; Jiaming Fan; Jing Wang; Zhicai Zhang; Chen Zhao; Zongyue Zeng; Yi Shu; Ruyi Zhang; Shujuan Yan; Yasha Li; Wenwen Zhang; Jing Cui; Chao Ma; Li Li; Yichun Yu; Tingting Wu; Xingye Wu; Jiayan Lei; Jia Wang; Chao Yang; Ke Wu; Ying Wu; Jun Tang; Bai-Cheng He; Zhong-Liang Deng; Hue H Luu; Rex C Haydon; Russell R Reid; Michael J Lee; Jennifer Moriatis Wolf; Wei Huang; Tong-Chuan He
Journal:  Oncotarget       Date:  2017-06-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.